Blog

Article of the Day, August 25th, suggested by IMMONC

Photo taken from Immune Oncology Research Institute/LinkedIn

Aug 26, 2024, 04:06

Article of the Day, August 25th, suggested by IMMONC

Immune Oncology Research Institute made the following post on LinkedIn:

“Article of the day suggested by the Immune Oncology Research Institute.
Author Affiliations: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University – The Feinberg School of Medicine.″

Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-Analysis

Authors: Anthony V. Serritella, MD, Niraj K. Shenoy, MD, PhD, MS.

Source: Immune Oncology Research Institute/LinkedIn

advanced cancers Anthony V. Serritella cancer Cancer research cancer treatment Feinberg School of Medicine Immune Oncology Research Institute ipilimumab melanoma research meta-analysis Niraj K. Shenoy nivolumab Northwestern University OncoDaily Oncology oncology study Robert H. Lurie Comprehensive Cancer Center

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer